Highlights Imagion Biosystems Limited

Equities

IBX

AU000000IBX6

Market Closed - Australian S.E. Other stock markets 04:50:03 28/03/2024 GMT			5-day change	1st Jan Change
0.074 ^AUD	-9.76%		-.--%	-79.15%

02-29	Imagion Biosystems Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01-15	Imagion Biosystems CEO Resigns	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Imagion Biosystems Limited Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
Imagion Biosystems Validates Safety, Feasibility of Breast Cancer Imaging Agent in Phase One Trial; Shares Rise 7%	12-06	MT
Imagion Biosystems Limited Announces Update on Magsense Her2 Program	02/10/23	CI
Imagion Biosystems Secures AU$3.5 Million R&D Tax Rebate for Fiscal Year 2022	19/09/23	MT
Imagion Biosystems Limited Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23	CI
Imagion Biosystems Completes Enrollment for Imaging Agent Trial; Shares Surge 25%	21/06/23	MT
Imagion Biosystems Limited Announces CEO Changes	18/06/23	CI
Imagion Biosystems Sets Timeline for Application Filing of US Phase 2 Study of Breast Cancer Imaging Agent	27/03/23	MT
Imagion Biosystems Limited Provides an Update on Development Plans for Its MagSense HER2 imaging agent	27/03/23	CI
Imagion Biosystems Secures Second Grant Funding for Prostate Cancer Imaging Technology	01/03/23	MT
Imagion Biosystems Limited Reports Positive Clinical Data At Breast Cancer Symposium	07/12/22	CI
Imagion Biosystems Limited Reports Earnings Results for the Half Year Ended June 30, 2022	24/08/22	CI
Imagion Biosystems Limited Provides Update on the Progress of First-In-Human Study for the MagSense HER2 Breast Cancer Imaging Agent	16/03/22	CI
Imagion Biosystems : 2021 Annual Report to Shareholders	24/02/22	PU
Imagion Biosystems Limited Enters into A Joint Development Agreement with Global Cancer Technology to Develop GCT's Novel Nanoscintillator Technology for the Treatment of Breast Cancer	17/09/21	CI
Imagion Biosystems Limited Reports Earnings Results for the Half Year Ended June 30, 2021	17/08/21	CI
Imagion Biosystems : Signs JV to Co-develop Nanocrystals for Breast Cancer Treatment; Shares Jump 8%	12/08/21	MT
Iimagion Biosystems Limited Announces It Has Entered into A Joint Development Agreement with Global Cancer Technology	12/08/21	CI
Imagion Biosystems Limited Announces First Patient Enrolled in the MagSense® HER2 Breast Cancer Phase I First-In-Human Study	26/05/21	CI
Patrys : Imagion Biosystems to Collaborate on Brain Tumor Imaging and Diagnosis Product; Shares Grow 8%	03/05/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Imagion Biosystems Limited

Equities

IBX

AU000000IBX6

Highlights

Filters